newsfilter
← Latest News
Business Wire·

CEL-SCI Appoints Dr. Gail Naughton to Its Board of Directors

Pioneer in the field of regenerative medicine who brought four products from concept through FDA approval and market launch CEL-SCI Corporation (NYSE:CVM) today announced the appointment of Dr. Gail K. Naughton to its Board of Directors. Dr. Naugh